Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Sanofi reception

FDA panel backs Sanofi’s insulin/GLP-1 agonist combo

iGlarLixi secures endorsement despite concern over its dosing and delivery device

Hansa Medical strengthens management team

Henk Doude van Troostwijk becomes vice president, commercial operations

Eli Lilly HQ

Lilly planning 20 new launches by 2023

Will focus on diabetes, immunology, oncology, neurodegeneration and pain

- PMLiVE

The Medicines Company appoints Biogen’s Tony Kingsley

He will be the New Jersey firm's president and COO

ABPI London offices

ABPI says UK role as clinical trial hub threatened by Brexit

Warns UK patients could be denied access to medical innovations as a result

Vectura to develop digitally-connected inhalers

Will collaborate with Propeller Health on sensor-enabled devices

- PMLiVE

Gilead Sciences appoints COO and strategy head

Kevin Young and Martin Silverstein join the leadership team

- PMLiVE

An effective commercial model for cancer care

Patient-centric cancer care

Celgene building

Celgene forms real-time, real-world trial partnership

Will collaborate with TriNetX, using its electronic medical records network

Novartis building

Novartis says Cosentyx is ‘outpacing competitors’

Claims new psoriasis drug has almost a third of the market share in Germany alone

- PMLiVE

FDA advisors back Novo Nordisk’s IDeglira combination

Unanimous vote is a step forward for the Tesiba-Victoza injection

National Institute for Health and Care Excellence NICE logo

NICE backs freer use of SGLT2 inhibitors for diabetes

Recommendation positions Invokana, Forxiga and Jardiance as first-line treatments

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links